Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Fahrenholz

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The European Journal of Neuroscience|October 26, 2010
The close link between retinoid signalling and the α-secretase ADAM10 and its potential for treating Alzheimer's disease (commentary on Jarvis et al.)Falk Fahrenholz
Current Alzheimer Research|October 3, 2007
Alpha-secretase as a therapeutic targetFalk Fahrenholz
Neuro-Degenerative Diseases|October 19, 2006
Alpha-secretase activation--an approach to Alzheimer's disease therapyFalk Fahrenholz, Rolf Postina
Sub-Cellular Biochemistry|February 16, 2005
The non-amyloidogenic pathway: structure and function of alpha-secretasesElzbieta Kojro, Falk Fahrenholz
Current Alzheimer Research|May 25, 2011
The Role of the anti-amyloidogenic secretase ADAM10 in shedding the APP-like proteinsKristina Endres, Falk Fahrenholz
Biochimica Et Biophysica Acta|August 15, 2002
Cholesterol as stabilizer of the oxytocin receptorGerald Gimpl, Falk Fahrenholz
The FEBS Journal|February 9, 2010
Upregulation of the alpha-secretase ADAM10--risk or reason for hope?Kristina Endres, Falk Fahrenholz
Experimental Brain Research|October 5, 2011
Regulation of α-secretase ADAM10 expression and activityKristina Endres, Falk Fahrenholz
Trends in Biochemical Sciences|December 7, 2002
A closer look at the cholesterol sensorGerald Gimpl, Katja Burger, Falk Fahrenholz
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's diseaseAnja Schroeder, Falk Fahrenholz, Ulrich Schmitt
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The European Journal of Neuroscience|October 26, 2010
The close link between retinoid signalling and the α-secretase ADAM10 and its potential for treating Alzheimer's disease (commentary on Jarvis et al.)Falk Fahrenholz
Current Alzheimer Research|October 3, 2007
Alpha-secretase as a therapeutic targetFalk Fahrenholz
Neuro-Degenerative Diseases|October 19, 2006
Alpha-secretase activation--an approach to Alzheimer's disease therapyFalk Fahrenholz, Rolf Postina
Sub-Cellular Biochemistry|February 16, 2005
The non-amyloidogenic pathway: structure and function of alpha-secretasesElzbieta Kojro, Falk Fahrenholz
Current Alzheimer Research|May 25, 2011
The Role of the anti-amyloidogenic secretase ADAM10 in shedding the APP-like proteinsKristina Endres, Falk Fahrenholz
Biochimica Et Biophysica Acta|August 15, 2002
Cholesterol as stabilizer of the oxytocin receptorGerald Gimpl, Falk Fahrenholz
The FEBS Journal|February 9, 2010
Upregulation of the alpha-secretase ADAM10--risk or reason for hope?Kristina Endres, Falk Fahrenholz
Experimental Brain Research|October 5, 2011
Regulation of α-secretase ADAM10 expression and activityKristina Endres, Falk Fahrenholz
Trends in Biochemical Sciences|December 7, 2002
A closer look at the cholesterol sensorGerald Gimpl, Katja Burger, Falk Fahrenholz
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's diseaseAnja Schroeder, Falk Fahrenholz, Ulrich Schmitt
Pageof 4